Great Information, Real Community, Better Living.
 Main Page
 Fibroids1 News
Feature Story
 Education Center

Find a Physician

Dr. Lauren Streicher  Fibroids

Dr. Lauren Streicher:
Educating Patients on their Options
About Heroes 
 Join the Discussion  in  Our Forums
Fibroids1 Forums
Patient Stories
One Question Poll


Online Resources
Patient Brochures
Locate a Specialist
Office Visits
    Asked Questions

Video Library

Search the Body1 Network
October 21, 2017  
FIBROIDS1 NEWS: Feature Story

  • Print this Article
  • Email this Article
  • Links/Reprints
  • Raloxifene for Fibroids

    Raloxifene for Fibroids

    March 12, 2004

    By Audrey Walton for Fibroids1

    A recent study suggests that raloxifene, a prescription drug most commonly used to treat osteoporosis in post-menopausal women, may also be useful in addressing fibroids. A report published by a team of researchers at the University of Vienna in Austria suggests that raloxifene reduces the size of fibroids while causing fewer side effects than hormone treatment, the more common drug therapy.
    Take Action
    Do not take raloxifene if:
  • You are pregnant or may become pregnant
  • You will be immobile for a long time
  • You currently have blood clots or have had them in the past
  • You have liver disease or are allergic to raloxifene or any of the ingredients found in raloxifene

  • The Austrian research team, led by Dr. Stefan Jirecek, performed the study on a group of 23 women, all of whom were pre-menopausal and had asymptomatic fibroids. Twelve of the women were placed in a control group, receiving no treatment, while the other 11 received raloxifene. Three months later, the fibroids in the women who received raloxifene were 9.1 percent smaller than they had been at the beginning of the study, while the fibroids in the women in the control group had increased in size by 13.1 percent—a total, or "absolute," difference of 22.2 percent.

    Moreover, as predicted, the researchers found that the drug had few side effects. Many drugs currently used to treat fibroids belong to a class of drugs known as "GnRH agonists," which interact directly with hormones and may have side effects such as bone loss. In the Austrian study, however, only one woman of the 11 experienced hot flashes, and the researchers reported no serious side effects or significant changes in the women’s hormone levels.

    Raloxifene is generally recommended for post-menopausal women. Used as a treatment for osteoporosis, it is generally safe but has been shown to cause blood clots in a small percentage of patients. While the drug has not yet been specifically approved for use in the treatment of fibroids, the findings of Dr. Jirecek and colleagues suggest that a new drug therapy for fibroids may be on the horizon.

    Last updated: 12-Mar-04


  • Add Comment
    Interact on Fibroids1

    Discuss this topic with others.
    Feature Archives

    Vitamin D May Reduce Risk Of Uterine Fibroids

    African-American Women Who Suffered Abuse During Childhood At Increased Risk For Uterine Fibroids

    Nonsurgical Treatment For Uterine Fibroids

    Genetic Risk Discovered For Uterine Fibroids

    Breakthrough In Genetics Of Fibroids

    Previous 5 Features ...

    Next 5 Features ...

    More Features ...
    Related Multimedia

    Interview with James Spies, M.D. - Treating and Evaluating Patients with Fibroids

    Interview with James Spies, M.D. - Fibroids: Who should be treated and who should not?

    Interview with James Spies, M.D. - Fibroids, Symptoms and Benefits of the Solution

    More Features ...
    Related Content
    GnRH Agonists Play Role in Bone Loss

    Reimbursement Support is Available to Fibroid Patients

    UFE Offers Patients Relief and Results

    Pregnancy Possible After UFE Procedure

    Fibroids – When the Source of Heavy Bleeding Evades Diagnosis

    More Features ...
    Home About Us Press Jobs Advertise With Us Contact Us
    © 2017 Body1 All rights reserved.
    Disclaimer: The information provided within this website is for educational purposes only and is not a substitute for consultation with your physician or healthcare provider. The opinions expressed herein are not necessarily those of the Owners and Sponsors of this site. By using this site you agree to indemnify, and hold the Owners and Sponsors harmless, from any disputes arising from content posted here-in.